Pi Pharma Intelligence instant reports Request a report by clicking here.

Webinar: Navigating the Saudi Market: Insights into Incentives and New Regulatory Frameworks

Event Date : 22-Jun-2025

In partnership with TOPRA, we’re excited to present an exclusive session by Pi Pharma Intelligence and HEPA Digital, focusing on critical topics shaping market access and regulatory developments in Saudi Arabia.

This session highlights the opportunities available for companies entering the Saudi market and offers guidance on aligning with its specific requirements. Key topics covered include:

- Latest Incentives for Accessing the Saudi Market.

- This session will provide valuable insights into the latest government initiatives and incentives designed to facilitate market access in Saudi Arabia. Learn about the opportunities and the strategies that can help pharmaceutical companies successfully enter and expand in the Saudi market.

- New Regulations Regarding Economic Evaluation Studies in the Saudi Market.

- Stay informed about the new regulations governing economic evaluation studies in Saudi Arabia. Our experts will guide you through the latest requirements and how these regulations influence market entry, product evaluation, and development strategies in the country.

Don’t miss out on this exclusive session, request the slides and session video

Leveraging AI for Drug Repurposing: A New Frontier in Pharmaceutical Innovation

Nov, 2024

Explore how artificial intelligence (AI) is revolutionizing drug repurposing, offering new avenues for pharmaceutical innovation.

Innovative Patient Engagement Strategies: Leveraging Tech to Connect Worldwide

May, 2024

Learn about the latest technological advancements that are transforming patient engagement in the pharmaceutical industry.

Entrada estratégica en el mercado: uso de los datos previos a la comercialización en la región MENA para la farmacia española

Sep, 2024

Descubra la clave del éxito para la entrada en el mercado de la región MENA para las empresas farmacéuticas españolas mediante el uso estratégico de los datos previos a la comercialización.